KAUR, MANMEET, and SAURAV MISRA. “REMTERNETUG: AN INVESTIGATIONAL MONOCLONAL ANTIBODY AGAINST Β-AMYLOID FOR THE TREATMENT OF ALZHEIMER’S DISEASE (AD)”. International Journal of Current Pharmaceutical Research, vol. 17, no. 3, May 2025, pp. 7-9, doi:10.22159/ijcpr.2025v17i3.55038.